(Q37089137)

18 August 2017

title

Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience (English)

1 reference

18 August 2017

0 references

1 reference

7

David J Sugarbaker

1 reference

18 August 2017

5

Elizabeth H Baldini

1 reference

18 August 2017

Aaron M Allen

1

1 reference

18 August 2017

Steven J Mentzer

2

1 reference

18 August 2017

Beow Y Yeap

3

1 reference

18 August 2017

Ricardo Soto

4

1 reference

18 August 2017

Michael S Rabin

6

1 reference

18 August 2017

Raphael Bueno

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

112

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

1106-1113

1 reference

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Survival and prognosis following resection of primary non small cell bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Impact of hospital volume on operative mortality for major cancer surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Results of radical treatment of stage IIIa non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Results of surgical treatment of stage III lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Long-term survival of surgical cases of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Surgeon specialty and operative mortality with lung resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

The influence of hospital volume on survival after resection for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

The effectiveness of high dependency unit in the management of high risk thoracic surgical cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23283

7 January 2021

Identifiers

DOI

10.1002/CNCR.23283

1 reference

18 August 2017

1 reference